JP7258031B2 - 機能性核酸分子及びその使用 - Google Patents

機能性核酸分子及びその使用 Download PDF

Info

Publication number
JP7258031B2
JP7258031B2 JP2020537887A JP2020537887A JP7258031B2 JP 7258031 B2 JP7258031 B2 JP 7258031B2 JP 2020537887 A JP2020537887 A JP 2020537887A JP 2020537887 A JP2020537887 A JP 2020537887A JP 7258031 B2 JP7258031 B2 JP 7258031B2
Authority
JP
Japan
Prior art keywords
ires
nucleic acid
sequence
functional nucleic
acid molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020537887A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020535845A5 (https=
JP2020535845A (ja
Inventor
グスティンシチ ステファノ
ズッチェルリ シルビア
Original Assignee
フォンダジオネ イスティツト イタリアノ ディ テクノロジア
スクオラ インターナジオナレ スペリオレ ディ ステュディ アバンザティ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フォンダジオネ イスティツト イタリアノ ディ テクノロジア, スクオラ インターナジオナレ スペリオレ ディ ステュディ アバンザティ filed Critical フォンダジオネ イスティツト イタリアノ ディ テクノロジア
Publication of JP2020535845A publication Critical patent/JP2020535845A/ja
Publication of JP2020535845A5 publication Critical patent/JP2020535845A5/ja
Application granted granted Critical
Publication of JP7258031B2 publication Critical patent/JP7258031B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3519—Fusion with another nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/50—Biochemical production, i.e. in a transformed host cell
    • C12N2330/51—Specially adapted vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/10—Vectors comprising a special translation-regulating system regulates levels of translation
    • C12N2840/105—Vectors comprising a special translation-regulating system regulates levels of translation enhancing translation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2020537887A 2017-09-20 2018-09-20 機能性核酸分子及びその使用 Active JP7258031B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102017000105372A IT201700105372A1 (it) 2017-09-20 2017-09-20 Molecola di acido nucleico funzionale e relativo uso
IT102017000105372 2017-09-20
PCT/IB2018/057262 WO2019058304A1 (en) 2017-09-20 2018-09-20 FUNCTIONAL NUCLEIC ACID MOLECULE AND ASSOCIATED APPLICATIONS

Publications (3)

Publication Number Publication Date
JP2020535845A JP2020535845A (ja) 2020-12-10
JP2020535845A5 JP2020535845A5 (https=) 2021-09-09
JP7258031B2 true JP7258031B2 (ja) 2023-04-14

Family

ID=61024873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020537887A Active JP7258031B2 (ja) 2017-09-20 2018-09-20 機能性核酸分子及びその使用

Country Status (8)

Country Link
US (1) US11649456B2 (https=)
EP (1) EP3684928A1 (https=)
JP (1) JP7258031B2 (https=)
KR (1) KR102677300B1 (https=)
CN (1) CN111386344B (https=)
CA (1) CA3076163A1 (https=)
IT (1) IT201700105372A1 (https=)
WO (1) WO2019058304A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900011490A1 (it) * 2019-07-11 2021-01-11 Scuola Int Superiore Di Studi Avanzati Sissa MOLECOLE DI ACIDO NUCLEICO FUNZIONALI CHE AUMENTANO LA TRADUZIONE DI UN mRNA DELLA FRATASSINA
CN110484563B (zh) * 2019-07-25 2023-04-07 新乡医学院 哺乳动物细胞组合表达载体、表达系统、制备方法和应用
CN116322791A (zh) 2020-09-24 2023-06-23 意大利技术基金会 经修饰的功能性核酸分子
CA3196633A1 (en) * 2020-10-08 2022-04-14 Scuola Internazionale Superiore Di Studi Avanzati Functional nucleic acid molecules
EP3992289A1 (en) 2020-10-30 2022-05-04 Transine Therapeutics Limited Functional nucleic acid molecules incorporating protein binding domain
CN112126644B (zh) * 2020-11-25 2021-03-12 北京立康生命科技有限公司 一种非依赖帽结构下进行细胞外转录的mRNA、呈递细胞及应用
EP4063505A1 (en) * 2021-03-22 2022-09-28 Fondazione Istituto Italiano di Tecnologia Functional nucleic acid molecules directed to targets for nervous system disorders
GB202205423D0 (en) 2022-04-12 2022-05-25 Transine Therapeutics Ltd Functional nucleic acid molecule
GB202207796D0 (en) 2022-05-26 2022-07-13 Fondazione St Italiano Tecnologia Functional nucleic acid molecule
GB202207795D0 (en) 2022-05-26 2022-07-13 Fondazione St Italiano Tecnologia Functional nucleic acid molecule
CN116004696B (zh) * 2023-02-01 2024-03-29 郑州贝贝生物科技有限公司 可与IRES组合的3ˊUTR加茎环结构基因及其应用、mRNA表达系统
KR20240132212A (ko) * 2023-02-24 2024-09-03 서울시립대학교 산학협력단 DNA 템플릿 및 이를 이용하여 제조된 mRNA 백신
CN117947028A (zh) * 2023-12-29 2024-04-30 北京衡昱生物科技有限公司 Ires-w3-31序列及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006506984A (ja) 2002-10-23 2006-03-02 イントロン，インコーポレーテッド 効率的なプレ−トランス−スプライシング分子の同定のためのスクリーニング方法
US20070136890A1 (en) 2003-07-03 2007-06-14 Board Of Trustees Operating Michigan State University Expression of a recombinant transgene
WO2012133947A1 (en) 2011-03-30 2012-10-04 Riken Functional nucleic acid molecule and use thereof
JP2015535430A (ja) 2012-11-26 2015-12-14 モデルナ セラピューティクス インコーポレイテッドＭｏ 末端修飾ｒｎａ

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869779B1 (en) * 1998-08-27 2005-03-22 Fuso Pharmaceutical Industries, Ltd. Nucleic acid sequence for potentiating the expression of useful gene and method therefor
US7468275B2 (en) * 2000-01-28 2008-12-23 The Scripps Research Institute Synthetic internal ribosome entry sites and methods of identifying same
TWI300441B (en) * 2005-09-21 2008-09-01 Univ Chung Yuan Christian A polynucleotide with ires activity
KR101161622B1 (ko) * 2009-08-31 2012-07-04 헬릭스 주식회사 번역 효율 증진용 ｄｎａ 단편 및 이를 포함하는 재조합 벡터
EP3241902B1 (en) * 2012-05-25 2018-02-28 The Regents of The University of California Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
CA2894684A1 (en) * 2012-12-12 2014-06-19 The Broad Institute, Inc. Engineering and optimization of improved crispr-cas systems, methods and enzyme compositions for sequence manipulation in eukaryotes
CN105624156B (zh) * 2014-11-04 2021-07-16 清华大学 含有反向sineb2重复序列的人工非编码rna及其在增强靶蛋白翻译中的用途
DK3350327T3 (en) * 2015-10-23 2019-01-21 Caribou Biosciences Inc CONSTRUCTED CRISPR CLASS-2-NUCLEIC ACID TARGETING-NUCLEIC ACID

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006506984A (ja) 2002-10-23 2006-03-02 イントロン，インコーポレーテッド 効率的なプレ−トランス−スプライシング分子の同定のためのスクリーニング方法
US20070136890A1 (en) 2003-07-03 2007-06-14 Board Of Trustees Operating Michigan State University Expression of a recombinant transgene
WO2012133947A1 (en) 2011-03-30 2012-10-04 Riken Functional nucleic acid molecule and use thereof
JP2015535430A (ja) 2012-11-26 2015-12-14 モデルナ セラピューティクス インコーポレイテッドＭｏ 末端修飾ｒｎａ

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Biochem. Soc. Trans., 2010年，Vol.38，p.1581-1586，doi:10.1042/BST0381581
RNA Biology, 2015年，Vol.12, No.8，p.771-779，http://dx.doi.org/10.1080/15476286.2015.1060395
トランスサインテクノロジーズ株式会社製品のSINEUPの販売を開始しました, 2013年，ニュース・イベント，（株）ダナフォーム，p.1-3，https://www.dnaform.jp/ja/information/20130320_1/, 検索日：2022年6月14日

Also Published As

Publication number Publication date
KR20200117975A (ko) 2020-10-14
US11649456B2 (en) 2023-05-16
IT201700105372A1 (it) 2019-03-20
CN111386344A (zh) 2020-07-07
WO2019058304A1 (en) 2019-03-28
CN111386344B (zh) 2024-02-02
KR102677300B1 (ko) 2024-06-24
US20200224197A1 (en) 2020-07-16
CA3076163A1 (en) 2019-03-28
JP2020535845A (ja) 2020-12-10
EP3684928A1 (en) 2020-07-29

Similar Documents

Publication Publication Date Title
JP7258031B2 (ja) 機能性核酸分子及びその使用
Rahman et al. Recurrent SRSF2 mutations in MDS affect both splicing and NMD
Dumbovic et al. Emerging roles of macrosatellite repeats in genome organization and disease development
Buratti et al. RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon
Ponicsan et al. Genomic gems: SINE RNAs regulate mRNA production
Van Eden et al. Demonstrating internal ribosome entry sites in eukaryotic mRNAs using stringent RNA test procedures
Paek et al. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA
Chatterjee et al. Role of 5′‐and 3′‐untranslated regions of mRNAs in human diseases
Merrill et al. Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNA-binding protein 76
Vivinus et al. An element within the 5′ untranslated region of human Hsp70 mRNA which acts as a general enhancer of mRNA translation
Toribio et al. An RNA trapping mechanism in Alphavirus mRNA promotes ribosome stalling and translation initiation
Abaeva et al. Attachment of ribosomal complexes and retrograde scanning during initiation on the Halastavi arva virus IRES
May et al. A sequence-independent, unstructured internal ribosome entry site is responsible for internal expression of the coat protein of turnip crinkle virus
Matsuda et al. Determinants of initiation codon selection during translation in mammalian cells
CN106520829B (zh) 一种终止双等位基因转录的方法
Willcocks et al. Distinct roles for the IIId2 sub-domain in pestivirus and picornavirus internal ribosome entry sites
Cheng et al. Aberrant splicing events caused by insertion of genes of interest into expression vectors
Kim et al. Staufen1-mediated mRNA decay induces Requiem mRNA decay through binding of Staufen1 to the Requiem 3′ UTR
Clark et al. Conserved nucleotides within the J domain of the encephalomyocarditis virus internal ribosome entry site are required for activity and for interaction with eIF4G
Pedersen et al. Human insulin-like growth factor II leader 2 mediates internal initiation of translation
Okada et al. Dissection of the beta-globin replication-initiation region reveals specific requirements for replicator elements during gene amplification
EP1002082B1 (en) Transcriptional silencer protein nrf
Nair et al. Sizing, stabilising, and cloning repeat-expansions for gene targeting constructs
Krivtsova et al. Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma
WO2023227769A1 (en) Functional nucleic acid molecule

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200630

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210727

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210727

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220712

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221011

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221227

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230307

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230404

R150 Certificate of patent or registration of utility model

Ref document number: 7258031

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250